Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 2002
Publications 2002

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Heo M et al. A meta-analytic investigation of linkage and association of common leptin receptor (LEPR) polymorphisms with body mass index an waist circumference.
2 Böhm J et al. Hyaluronan expression in differentiated thyroid carcinoma.
3 Chiasson J-L et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial.
4 Dickstein K et al. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial.
5 Erhardt L et al. Task force on the management of chest pain.
6 Eriksson JG et al. The effects of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 gene on insulin sensitivity and insulin metabolism interact with size at birth.
7 Erkkilä AT et al. Association of leucine 7 to proline 7 polymorphism in the preproneuropeptide Y with serum lipids in patients with coronary heart disease.
8 Erkkilä AT et al. Variation in the fatty acid binding protein 2 gene is not associated with markers of metabolic syndrome in patients with coronary heart disease.
9 Follath F et al. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
10 Geelen G et al. Gender influence on vasoactive hormones at rest and during a 70o head-up tilt in healthy humans.
11 Ghali JK et al. Metoprolol CR/XL in female patients with heart failure: Analysis of the experience in metoprolol extended-release randomized intervention trial in heart failure (MERIT-HF).
12 González Sánchez JL et al. Effect of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma-2 gene on adiposity, insulin sensitivity and lipid profile in the Spanish population.
13 Gottlieb SS et al. Tolerability of beta-blocker initiation and titration in the metoprolol CR/XL randomized intervention trial in congestive heart failure (MERIT-HF).
14 Haapala I et al. Anthropometry, bioelectrical impedance and dual-energy X-ray absorptiometry in the assessment of body composition in elderly Finnish women.
15 Hakala T et al. Intraoperative high-rate atrial pacing test as a predictor of atrial fibrillation after coronary artery bypass surgery.
16 Hannonen P. Pehmytkudosten kiputilat.
17 Hartikainen J. Akuutin sydäninfarktin komplikaatiot ja niiden hoito.
18 Hartikainen J. Akuutin sydäninfarktin diagnostiikka.
19 Hartikainen J. Akuutin sydäninfarktin hoito ja potilaan valvonta.
20 Hedman A, Hakinen M. Rytmihäiriötahdistin (ICD) tehohoitopotilailla.
21 Hedman A, Halinen M. Kammioperäisten rytmihäiriöiden hoito.
22 Hedman A, Halinen M. Tehohoitopotilaan rytmihäiriöiden hoito.
23 Hedman A, Halinen M. Supraventrikulaaristen rytmihäiriöiden hoito.
24 Hedman A, Halinen M. Bradyarytmioiden hoito.
25 Hedman A, Halinen M. Rytmihäiriölääkkeisiin liittyviä kliinisiä kysymyksiä.
26 Hedman A, Halinen M. Sydämen väliaikaisen tahdistimen aiheet.
27 Hedman A, Halinen M. Sydämentahdistimen mahdollisia ongelmia.
28 Heino A et al. Effects of fluid and dobutamine treatment on renal function during partial superior mesenteric artery occlusion and reperfusion.
29 Herlitz J et al. Effects of metoprolol CR/XL on mortality and hospitalizations in patients with heart failure and history of hypertension.
30 Huopio H et al. Acute insulin response tests for the differential diagnosis of congenital hyperinsulinism.
31 Huopio H et al. Carriers of an inactivating beta-cell ATP-sensitive K+ channel mutation have normal glucose tolerance and insulin sensitivity and appropriate insulin secretion.
32 Häkkinen K et al. Effects of strength training on muscle strength, cross-sectional area, maximal electromyographic activity, and serum hormones in premenopausal women with fibromyalgia.
33 Janatuinen EK et al. No harm from five year ingestion of oats in coeliac disease.
34 Jantunen E. Bisphosphonate therapy in multiple myeloma: past, present, future.
35 Jantunen E et al. Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
36 Jantunen E et al. A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeoloma patients.
37 Jantunen E et al. Suurten granulaisten lymfosyyttien leukemia.
38 Jantunen E et al. Radiologically guided fine needle lung biopsies in the evaluation of focal pulmonary lesions in allogeneic stem cell transplant recipients.
39 Jääskeläinen P. Molecular Genetics of Hypertrophic Cardiomyopathy in Eastern Finland.
40 Jääskeläinen P et al. Mutations in the cardiac myosin-binding protein C gene are the predominant cause of familial hypertrophic cardiomyopathy in eastern Finland.
41 Kaarisalo MM et al. The risk of stroke following coronary revascularization - a population-based long-term follow-up study.
42 Koukkunen H. Biochemical Markers in the Diagnostic and Prognostic Evaluation of Acute Coronary Syndromes.
43 Kvien TK et al. Long term efficacy and safety of cyclosporin versus parenteral gold in early rheumatoid arthritis: a three year study of radiographic progression, renal function, and arterial hypertension.
44 Kärkkäinen S et al. No variants in the cardiac actin gene in Finnish patients with dilated or hypertrophic cardiomyopathy.
45 Laakso M. Lipids in type 2 diabetes.
46 Laakso M. Diabetic macrovascular complications.
47 Laakso M. The heavy burden of cardiovascular disease in type 2 diabetes.
48 Laaksonen DE et al. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study.
49 Laaksonen DE et al. Low levels of leisure-time physical activity and cardiorespiratory fitness predict development of the metabolic syndrome.
50 Laaksonen DE et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men.
51 Laasanen J et al. Polymorphism in the peroxisome proliferator-activated receptor-gamma gene in women with preeclampsia.
52 Lakka H-M et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
53 Lehto S et al. Association between Chlamydia pneumoniae antibodies and intimal calcification in femoral arteries of nondiabetic patients.
54 Lindi VI et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
55 Majamaa-Voltti K et al. Cardiac abnormalities in patients with mitochondrial DNA mutation 3243A>G.
56 Mayer O Jr et al. The pursuit of secondary prevention targets in Czech coronary patients. a comparison of Euroaspire I and II surveys.
57 Mussalo H et al. Baroreflex sensitivity in essential and secondary hypertension.
58 Myllykangas-Luosujärvi R. Nivelrikon lääkehoito.
59 Myllykangas-Luosujärvi R. Milloin epäilen potilaallani nivelreumaa?
60 Myllykangas-Luosujärvi R et al. Comparison of low-dose rofecoxib versus 1000 mg naproxen in patients with osteoarthritis.
61 Myllykangas-Luosujärvi R et al. A cluster of inflammatory rheumatic diseases in a moisture-damaged office.
62 Mäkinen K et al. Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: A randomized, placebo-controlled, double-blinded phase II study.
63 Möttönen T et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis.
64 Möttönen T et al. Antireumaattiset lääkkeet.
65 Niskanen L et al. ACE inhibitor as one of several possible first-Line agents is reasonable for diabetic patients with hypertension.
66 Niskanen L et al. Does postmenopausal hormone replacement therapy affect cardiac autonomic regulation in osteoporotic women?
67 Nousiainen T et al. Early decline in left ventricular ejection fraction predicts doxorubicin cardiotoxicity in lymphoma patients.
68 Nousiainen T et al. Concomitant impairment of left ventricular systolic and diastolic function during doxorubicin therapy: A prospective radionuclide ventriculographic and echocardiographic study.
69 Nousiainen T et al. Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction.
70 Oinonen R et al. Autologous stem cell transplantation in patients with mantle cell lymphoma.
71 Paimela H et al. Current features of peptic ulcer disease in Finland: incidence of surgery, hospital admissions and mortality for the disease during the past twenty-five years.
72 Pajunen P et al. Serum homocysteine, creatinine, and glucose as predictors of the severity and extent of coronary artery disease in asymptomatic members of high-risk families.
73 Penttilä K et al. Serum and plasma as alternative sample types in analysis of cardiac markers in the clinical routine.
74 Penttilä K et al. Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain.
75 Perola O et al. Recurrent Sphingomonas paucimobilis-bacteraemia associated with a multi-bacterial water-borne epidemic among neutropenic patients.
76 Pirskanen M et al. Interleukin 1 alpha gene polymorphism as a suscetibility factor in Alzheimer´s disease and its influence on the extend of histopathological hallmark lesions of Alzheimer´s sisease.
77 Qiao Q et al. Two-hour glucose is a better risk predictor for incident coronary heart disease and cardiovascular mortality than fasting glucose.
78 Redberg RF et al. Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group III: risk assessment in persons with diabetes.
79 Renkonen-Sinisalo L et al. No support for endoscopic surveillance for gastric cancer in hereditary non-polyposis colorectal cancer.
80 Saha MT et al. Time course of serum prolactin and sex hormones following successful renal transplantation.
81 Salomaa V et al. Sepelvaltimotautitapahtumien esiintyvyyden kehityssuunnat Suomessa 1993-1997: FINAMI-tutkimus.
82 Simula S et al. Cardiac adrenergic innervation is affected in asymptomatic subjects with very early stage of coronary artery disease.
83 Still A-M et al. Impaired negative chronotropic response to adenosine in patients with inappropriate sinus tachycardia.
84 Tuomainen P et al. Characterization of the warm-up phenomenon in patients with coronary artery disease.
85 Uusimaa P et al. Serum lipoprotein(a) level in relation to severity of coronary artery disease and coronary artery patency in acute myocardiial infarction.
86 Vakkilainen J et al. Genetic influences contributing to LDL particle siz in familial combined hyperlipidaemia.
87 Voutilainen-Kaunisto R et al. Iris transluminance in type 2 diabetes.
88 Wikstrand J et al. Dose of metoprolol CR/XL and clinical outcomes in patiets with heart failure: Analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008